You are here: Industry Insights > clinical trials

News List

Echinacea Extract: Therapeutic Potential and Traditional Uses David Orchard-Webb
November 05, 2024
Echinacea is known for its brilliant purple petals and cone-shaped core, has been used for generations for medicinal purposes.
The Transformative Role of Generative AI (genAI) in the Pharmaceutical Industry David Orchard-Webb
April 01, 2024
The future of genAI in pharmaceuticals is bright, promising a healthier, more efficient approach to drug development and patient care.
Vetter Earns Prestigious Honors Across All Core Categories in the 13th Annual CDMO Leadership Awards PharmaSources
March 27, 2024
Vetter once again earned the 2024 CDMO Leadership Awards in all six core categories – quality, expertise, reliability, capabilities, compatibility and service for big pharma, small pharma and overall respondents.
Why Diverse Representation in Clinical Research Matters Suzanne Elvidge
March 19, 2024
Randomised controlled trials (RCTs), where study participants are randomly allocated to an experimental group or a control group, became the ‘gold standard’ of clinical research in the mid-20th century.
Understanding clinical trials in approval of novel medication into the health market Shruti Talashi
December 01, 2023
The first step in creating a new medication is to gain as much knowledge as you can about the illness or condition. Basic research offers hints about prospective treatment approaches for illnesses, including addressing their symptoms or underlying causes.
Breakthroughs in Melanoma Immunotherapy & RNA Vaccines Daivd Orchard Webb/PharmaSources
July 03, 2023
Melanoma is a type of skin cancer that develops from pigment-producing cells called melanocytes.
The Dynamic Diabetes and Metabolic Disorder Treatment Landscape Daivd Orchard Webb/PharmaSources
July 03, 2023
Diabetes is a chronic medical condition characterized by high levels of glucose in the blood.
Weekly Pharma News Review | PharmaSources.com (May.6th to May.15th) PharmaSources.com
May 18, 2022
The most encouraging news this week is that the international, multicenter, Phase III clinical trials of Hengrui's PD-1 combination therapy for liver cancer have been announced to be successful.
Weekly Pharma News Review | PharmaSources.com （April.18th - 22ed） PharmaSources.com
April 27, 2022
The pharma news review of this week totally covers 22 pieces of news in 3 sections, including drug review, R&D, and business.
With the BGB-16673 Clinical Trials of BeiGene Launched, PROTAC Leads a Brand New Trend of Global Competition PharmaSources/Wanghong
March 21, 2022
On February 28, BGB-16673, a BTK-targeted PROTAC drug of BeiGene, was launched for clinical trials for the first time in China.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 13 14 Next page